Rodrigo Pagani

Rodrigo Pagani serves as CEO Brasil at Reprogenetics. Reprogenetics operates in the research sector with approximately 55.0 employees. The company is headquartered in Chicago, Illinois.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,772 executive contacts are available in Illinois.
• • Our database includes 201,469 c suite-level executives.

Gmail Google Apps Android

pgt pgta pgtm pgtsr reproductive genetics receptividad endometrial microbioma inmunologia factor masculino preimplantation genetic testing test genetico preimplantacional biotechnology research genetics genetic testing personalized genetic services clinical applications innovative solutions research & innovation patient support genetic consulting highly qualified professionals dynamic solutions genetic research clinical genetics genetic counseling patient needs genetic analysis medical genetics laboratory services genomic solutions biotechnology genetic diagnostics clinical research healthcare solutions patient-centered care genomic medicine precision medicine clinical trials health innovation diagnostic services genetic screening data analysis patient education genetic risk assessment clinical laboratories medical research bioinformatics genetic profiles genetic interpretation health technology genetic biomarkers patient outcomes clinical workflow laboratory management genetic databases genetic risk prediction patient engagement genomic testing health care health wellness & fitness hospital & health care data analytics information technology & services

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Rodrigo Pagani in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Reprogenetics.

Rodrigo Pagani's Position in the MessageCEO Database

• •Rodrigo Pagani is 1 of 1 verified executive contact we track at Reprogenetics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,510 verified executive contacts in Illinois are in the database.
• •30 verified contacts work at research companies in the 55.0 employee range (same size as Reprogenetics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Rodrigo Pagani directly?

Rodrigo Pagani's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO Brasil at Reprogenetics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Rodrigo Pagani work for?

Rodrigo Pagani is CEO Brasil at Reprogenetics, a company in the research sector with 55.0 employees. The company is based in Chicago, Illinois.

Can I pitch or sell to Rodrigo Pagani?

As CEO Brasil at Reprogenetics, Rodrigo Pagani is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Rodrigo Pagani directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Rodrigo Pagani in?

Rodrigo Pagani works in the research industry as CEO Brasil at Reprogenetics. MessageCEO provides verified contact information for executives across all major industries.

Is Rodrigo Pagani's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Rodrigo Pagani's profile is kept up-to-date with the latest available information.

Last updated: July 19, 2026